Tickwind
TodayOpportunitiesMarketsHotNewsAI Chat
What's new
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

VPG vs NOVT

VPG and NOVT side by side — valuation & fundamentals (public data).

Key statistics

VPG vs NOVT key statistics
MetricVPGVishay Precision Group, Inc.NOVTNOVANTA INC
Market cap$1.07B$4.95B
P/E (TTM)194.8100.0
P/B3.213.77
P/S3.5x5.0x
Revenue$319.81M(TTM)$1.00B(TTM)
Revenue growth (YoY)0.2%3.3%
Net income$5.92M(TTM)$53.72M(TTM)
Earnings growth (YoY)-46.6%-16.0%
EPS, diluted$0.45(TTM)$1.39(TTM)
EBIT margin4.5%9.6%
ROE1.6%4.1%
ROIC2.8%6.4%
Piotroski F5/96/9
1y total return+222.3%+13.0%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: VPG vs NOVT

$10.0K$61.8K$98.8K2016-03-292026-07-30
MetricVPGNOVT
End value$61.8K$98.8K
Total return+517.9%+888.0%
CAGR+19.3%+24.8%
Volatility42.9%38.8%
Sharpe0.530.67
Sortino0.830.99
Max drawdown-60.0%-46.7%

Based on 2600 common trading days, 2016-03-29 → 2026-07-30 · risk-free 3.83% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

AAPL vs MSFTGOOGL vs METAAMZN vs GOOGLMSFT vs GOOGLMETA vs NFLXORCL vs MSFT

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)